Dendritic cell‐based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model

BACKGROUND: Tumour‐specific cytotoxic T lymphocytes (CTLs) can be activated in vivo by vaccination with dendritic cells (DCs). However, clinical responses to DC‐based vaccination have only been observed in a minority of patients with solid cancer. Combination with other treatment modalities such as...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bauer, C, Bauernfeind, F, Sterzik, A, Orban, M, Schnurr, M, Lehr, H A, Endres, S, Eigler, A, Dauer, M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2007
Gaiak:
Pancreatic Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1954993/
https://ncbi.nlm.nih.gov/pubmed/17395611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2006.108621
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak